180 related articles for article (PubMed ID: 24895075)
1. Novel dexamethasone-loaded nanomicelles for the intermediate and posterior segment uveitis.
Vaishya RD; Gokulgandhi M; Patel S; Minocha M; Mitra AK
AAPS PharmSciTech; 2014 Oct; 15(5):1238-51. PubMed ID: 24895075
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of dexamethasone nanomicelles with potential for treating posterior uveitis after topical application.
Patel S; Garapati C; Chowdhury P; Gupta H; Nesamony J; Nauli S; Boddu SH
J Ocul Pharmacol Ther; 2015 May; 31(4):215-27. PubMed ID: 25839185
[TBL] [Abstract][Full Text] [Related]
3. Functional chitosan oligosaccharide nanomicelles for topical ocular drug delivery of dexamethasone.
Xu X; Sun L; Zhou L; Cheng Y; Cao F
Carbohydr Polym; 2020 Jan; 227():115356. PubMed ID: 31590850
[TBL] [Abstract][Full Text] [Related]
4. A grafted copolymer-based nanomicelles for topical ocular delivery of everolimus: Formulation, characterization, ex-vivo permeation, in-vitro ocular toxicity, and stability study.
Mehra N; Aqil M; Sultana Y
Eur J Pharm Sci; 2021 Apr; 159():105735. PubMed ID: 33516808
[TBL] [Abstract][Full Text] [Related]
5. Sustained release micellar carrier systems for iontophoretic transport of dexamethasone across human sclera.
Chopra P; Hao J; Li SK
J Control Release; 2012 May; 160(1):96-104. PubMed ID: 22306336
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal administration of dexamethasone-loaded PLGA-TPGS nanoparticles for the treatment of posterior segment diseases.
Yang C; Jiang L; Bu S; Zhang L; Xie X; Zeng Q; Zhu D; Zheng Y
J Biomed Nanotechnol; 2013 Sep; 9(9):1617-23. PubMed ID: 23980509
[TBL] [Abstract][Full Text] [Related]
7. Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.
Vadlapudi AD; Cholkar K; Vadlapatla RK; Mitra AK
J Ocul Pharmacol Ther; 2014 Feb; 30(1):49-58. PubMed ID: 24192229
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.
Lowder C; Belfort R; Lightman S; Foster CS; Robinson MR; Schiffman RM; Li XY; Cui H; Whitcup SM;
Arch Ophthalmol; 2011 May; 129(5):545-53. PubMed ID: 21220619
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of anti-inflammatory impact of dexamethasone-loaded PCL-PEG-PCL micelles on endotoxin-induced uveitis in rabbits.
Alami-Milani M; Zakeri-Milani P; Valizadeh H; Sattari S; Salatin S; Jelvehgari M
Pharm Dev Technol; 2019 Jul; 24(6):680-688. PubMed ID: 30892119
[TBL] [Abstract][Full Text] [Related]
10. High drug payload nanoparticles formed from dexamethasone-peptide conjugates for the treatment of endotoxin-induced uveitis in rabbit.
Yu X; Zhang R; Lei L; Song Q; Li X
Int J Nanomedicine; 2019; 14():591-603. PubMed ID: 30666116
[TBL] [Abstract][Full Text] [Related]
11. Optimization of dexamethasone mixed nanomicellar formulation.
Cholkar K; Hariharan S; Gunda S; Mitra AK
AAPS PharmSciTech; 2014 Dec; 15(6):1454-67. PubMed ID: 24980081
[TBL] [Abstract][Full Text] [Related]
12. In Vitro/In Vivo Evaluation of Dexamethasone--PAMAM Dendrimer Complexes for Retinal Drug Delivery.
Yavuz B; Pehlivan SB; Vural İ; Ünlü N
J Pharm Sci; 2015 Nov; 104(11):3814-3823. PubMed ID: 26227825
[TBL] [Abstract][Full Text] [Related]
13. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
14. Formulation of Nanomicelles to Improve the Solubility and the Oral Absorption of Silymarin.
Piazzini V; D'Ambrosio M; Luceri C; Cinci L; Landucci E; Bilia AR; Bergonzi MC
Molecules; 2019 Apr; 24(9):. PubMed ID: 31052197
[TBL] [Abstract][Full Text] [Related]
15. Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer.
Tan BJ; Liu Y; Chang KL; Lim BK; Chiu GN
Int J Nanomedicine; 2012; 7():651-61. PubMed ID: 22334787
[TBL] [Abstract][Full Text] [Related]
16. PLA-PCL-PEG-PCL-PLA based micelles for improving the ocular permeability of dexamethasone: development, characterization, and
Alami-Milani M; Zakeri-Milani P; Valizadeh H; Fathi M; Salatin S; Salehi R; Jelvehgari M
Pharm Dev Technol; 2020 Jul; 25(6):704-719. PubMed ID: 32098567
[TBL] [Abstract][Full Text] [Related]
17. Topical, Aqueous, Clear Cyclosporine Formulation Design for Anterior and Posterior Ocular Delivery.
Cholkar K; Gilger BC; Mitra AK
Transl Vis Sci Technol; 2015 May; 4(3):1. PubMed ID: 25964868
[TBL] [Abstract][Full Text] [Related]
18. A nonionic surfactant/chitosan micelle system in an innovative eye drop formulation.
Pepić I; Hafner A; Lovrić J; Pirkić B; Filipović-Grcić J
J Pharm Sci; 2010 Oct; 99(10):4317-25. PubMed ID: 20310026
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tolerance study of intravitreal injection of dexamethasone-loaded nanoparticles in rabbits.
Zhang L; Li Y; Zhang C; Wang Y; Song C
Int J Nanomedicine; 2009; 4():175-83. PubMed ID: 19774116
[TBL] [Abstract][Full Text] [Related]
20. Combined Therapy of Experimental Autoimmune Uveitis by a Dual-Drug Nanocomposite Formulation with Berberine and Dexamethasone.
Huang C; Zhang Z; Gu J; Li D; Gao S; Zhang R; Shi R; Sun J
Int J Nanomedicine; 2023; 18():4347-4363. PubMed ID: 37545873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
